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Abstract
Aims/hypothesis High dietary salt intake has been associated
with elevated BP and may also have a deleterious effect on
microvascular complications. We studied the cross-sectional
associations between dietary salt intake (estimated from 24 h
urinary sodium excretion) and urinary potassium excretion on
the one hand, and the prevalence of microvascular complica-
tions on the other, in individuals with type 1 diabetes.
Methods We measured sodium and potassium concentrations
in two 24 h urine samples in 1,212 individuals with type 1
diabetes (40±10 years old, 51% men) who participated in the
EURODIAB Prospective Complications Study. We used mul-
tiple logistic regression analyses to investigate associations
between dietary salt intake and microvascular complications
adjusted for age and sex, and additionally for BMI, smoking,
urinary potassium excretion, antihypertensive medication and
physical activity, and total energy, protein, alcohol, saturated
fat and fibre intake.
Results After full adjustment, 1 g/day higher dietary salt
intake was positively associated with the presence of
microalbuminuria (OR 1.06 [95% CI 1.01, 1.10]), but not
macroalbuminuria (OR 0.99 [95% CI 0.94, 1.05]), non-
proliferative retinopathy (OR 1.00 (95% CI 0.96, 1.04]) or
proliferative retinopathy (OR 1.02 (95%CI 0.95, 1.08]). After
excluding individuals with cardiovascular disease and/or an-
tihypertensive medication (n=418), we found a non-
significant association with microalbuminuria (OR 1.04
[95% CI 0.99, 1.10]) and macroalbuminuria (OR 1.05 [95%
CI 0.96, 1.16]). The association between dietary salt intake
and microalbuminuria was stronger in individuals with a BMI
above 25 kg/m2 (OR 1.11 [95% CI 1.04, 1.18]) than in those
with BMI below 25 kg/m2 (OR 1.03 [95% CI 0.97, 1.09]). No
significant associations were found between urinary potassi-
um excretion and microvascular complications.
Conclusions/interpretation In individuals with type 1 diabe-
tes, higher dietary salt intake, as determined by 24 h urinary
sodium excretion, may be positively associated with
microalbuminuria, particularly in overweight individuals.
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Introduction
Nutritional advice is important in preventing or slowing the
rate of development of diabetes-related cardiovascular disease
(CVD). Nutritional advice that favourably affects cardiovas-
cular risk factors, such as BP, may also have a favourable
effect onmicrovascular complications such as retinopathy and
nephropathy [1, 2]. Lowering dietary salt intake is known to
reduce BP [3].
Several large cohort studies conducted in the general pop-
ulation have investigated associations between dietary salt
intake and prevalent microalbuminuria. In these studies die-
tary salt intake was estimated using either 24 h urinary sodium
excretion [4–6], which is currently regarded as the reference
method, or food frequency questionnaire (FFQ) [7, 8]. Both
null [4, 8] and positive [5–7, 9] associations have been found
between dietary salt intake and prevalent microalbuminuria in
the general population.
In contrast, a smaller study on 270 individuals with type 2
diabetes in which a spot urine sample was used to estimate
daily salt intake showed a ‘J-shaped’ association with albu-
minuria [10]. A J-shaped association was also found between
24 h urinary sodium excretion and all-cause mortality in
individuals with type 1 diabetes [11]. In this Finnish cohort,
low sodium excretion (the 10th percentile of the population)
was also associated with the development of end-stage renal
disease [11]. The association between dietary salt intake and
(early) microvascular complications in individuals with type 1
diabetes, however, has not yet been established, except for one
prospective study [12]. This study showed that in 469African-
American patients with type 1 diabetes a high dietary sodium
intake was associated with a higher 6 year incidence of mac-
ular oedema [12]. However, the authors used an FFQ to
estimate dietary salt intake and potassium intake was not taken
into account. High potassium intake has been shown to exert
an inhibitory effect on sodium sensitivity [13] and high sodi-
um intake in combination with low potassium intake results in
further increases in BP [13]. However, the association be-
tween potassium intake and microvascular complications in
type 1 diabetes has not yet been established.
We investigated the associations between sodium and po-
tassium intake, estimated from 24 h urine samples, and the
prevalence of microalbuminuria, macroalbuminuria, and
non-proliferative and proliferative retinopathy in a European
cohort of individuals with type 1 diabetes.
Methods
Study population We used data from the EURODIAB
Prospective Complications Study, a European based prospec-
tive cohort study that has been described in detail elsewhere
[14, 15]. In brief, baseline investigations were performed
between 1989 and 1991 on 3,250 patients with type 1 diabe-
tes, defined as clinical diagnosis made before the age of
36 years, and needing continuous insulin therapy within 1 year
of diagnosis. Patients aged 15–60 years were recruited from
31 centres in 16 European countries. Sample selection was
stratified by sex, age group and duration of diabetes to ensure
sufficient representation in all categories. These patients were
invited for a follow-up examination on average 7–9 years after
the baseline examinations. Of the 3,250 included patients,
1,880 (57.8%) returned for re-examination. We performed
cross-sectional analyses on these follow-up data (as urine
samples of the baseline investigations were no longer
available).
Ethics committee approval conforming to the Declaration
of Helsinki was obtained at each centre and all participants
provided written informed consent.
Urinary sodium and potassium excretion We measured uri-
nary sodium and potassium concentrations in one (n=119) or
two (n=1,093) 24 h urine samples of 1,212 individuals from
the EURODIAB follow-up measurement in 1997 by means of
an ion-selective electrode (Cobas 6000; Roche Diagnostics,
Tokyo, Japan). We multiplied 24 h urinary sodium excretion
(in g/day) by 2.5 to estimate the dietary salt intake (in g/day).
Microvascular complications The AER was measured from
duplicate 24 h urine collections using an immunoturbidimetric
method that included goat anti-human albumin antisera
(Sanofi Diagnostics Pasteur, Chaska, MN, USA) and human
serum albumin standards (ORHA 20/21 grade HSA; Behring
Diagnostics, Hoechst UK, Hounslow, UK) [16].
Microalbuminuria and macroalbuminuria were defined as
AER 20–200 μg/min and >200 μg/min, respectively. The
GFR was estimated using the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation [17].
Retinopathy was centrally assessed from retinal photo-
graphs by a trained reader of colour retinal photographs using
a system of 45° field grading standards for the assessment of
retinopathy that was developed for the EURODIAB
Prospective Complications Study. Non-proliferative retinopa-
thy was defined as the presence of one or more
microaneurysms, haemorrhages and/or hard exudates.
Proliferative retinopathy was defined as any new vessel,
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fibrous proliferations, pre-retinal haemorrhage, vitreous
haemorrhage or photocoagulation scar [18].
Covariables Weight and height were measured with indoor
clothing without shoes and BMI was calculated as weight
divided by height squared. Smoking habits were ascertained
by questionnaire and individuals were categorised into never
smokers, ex-smokers and current smokers. Self-reported
physical activity was assessed by a questionnaire. The weekly
metabolic equivalent (MET-h) corresponds to the weekly
amount of time spent in each sporting activity multiplied by
the corresponding MET value. Physical activity was then
categorised into none, low (less than or equal to the sex-
specific median; 9.6 MET-h/week for men and 7.3 MET-h/
week for women) and high (greater than the sex-specific
median).
A standardised 3 day dietary record was employed for
dietary assessment, as previously described [19]. Briefly, local
dietitians instructed individuals on how to record all food and
beverages consumed over 3 days (two workdays and a
Sunday) with the help of standardised food portion sizes.
The local dietitian reviewed each completed record with each
individual. Then, with the use of a centrally prepared
EURODIAB food list, the records were analysed to quantify
the amounts of total energy, total protein (animal and vegeta-
ble protein), total fat (saturated and unsaturated fat), total
carbohydrate, fibre and alcohol intake. Alcohol consumption
was categorised into none, low (less than or equal to the sex-
specific median; 12.7 g/day for men and 7.1 g/day for women)
and high (greater than the sex-specific median). We did not
quantify dietary salt intake based on dietary records as this is
considered unreliable due to recall bias, variations of sodium
content of common food items, lack of information on sodium
added during cooking or at the table and imprecision with
estimating portion size [20, 21].
Statistical analyses All statistical analyses were carried out
using the Predictive Analytics SoftWare, version 18.0 (SPSS
IBM Corporation, Armonk, NY, USA), unless specified oth-
erwise. Variables with a skewed distribution (i.e. GFR, triac-
ylglycerols) were loge transformed prior to all analyses.
General characteristics were compared between cate-
gories of urinary sodium excretion with the use of
ANOVA or χ2 tests for continuous or categorical data,
respectively.
In all, 378 individuals (31% of the total population) had
missing values for one or more of the covariables. The per-
centage of missing values per variable varied from 0.1%
(physical activity) to 17% (dietary intake). We used multiple
imputation chained equations to impute those missing values
rather than perform complete case analyses in order to de-
crease bias and increase the power of the analyses [22]. With
this procedure, the imputation model of a single missing
variable used the information from all the other variables
considered as predictors by appropriate regression models
(i.e. linear or logistic if variable to be imputed was continuous
or dichotomous, respectively). We generated five imputed
datasets, which were used to fit the regression models of
interest. The results reported were those retrieved from pooled
analyses on all five imputed datasets.
We used logistic regression analyses to investigate the
associations between dietary salt intake and potassium excre-
tion on the one hand and the prevalence of microvascular
complications on the other, after adjustment first for age and
sex (model 1), then additionally for BMI, smoking, urinary
potassium (in the case of sodium), urinary sodium (in the case
of potassium) and use of antihypertensive medication (model
2), and further for physical activity and total energy, protein,
saturated fat, fibre and alcohol intake (model 3). We investi-
gated these associations both with dietary salt intake divided
into categories of 7.5–10 and >10 g/day vs <7.5 g/day, and
with dietary salt intake as a continuous variable. We added
quadratic terms of salt intake to our models to statistically
examine potential non-linearity. To increase the power of our
analyses, we present the analyses with salt intake as a contin-
uous variable whenever no consistent non-linear associations
between dietary salt intake and microvascular complications
were found.
All regression analyses were conducted in the whole study
population and also in the subgroup of individuals without
prevalent CVD and/or antihypertensive medication, because
individuals with prior CVD and/or known (treated) hyperten-
sion may have received dietary advice to reduce their salt
intake, which may mask any associations. We additionally
tested for interaction by variables that may modify dietary salt
sensitivity at a given intake, i.e. urinary potassium excretion,
kidney function and BMI, on the multiplicative scale by
adding product terms between these variables and urinary
sodium excretion to the fully adjusted models and on the
additive scale by calculating the relative excess risk due to
interaction (RERI) [23]. CIs of the RERI were estimated by
using a bootstrap method with 10,000 bootstrap samples in R
statistical software, version 2.15.2 (http://www.r-project.org)
[23]. We stratified our analyses whenever significant
interactions were found.
We performed sensitivity analyses to investigate the
robustness of significant associations between dietary salt
intake and microvascular complications by excluding indi-
viduals with potential under or over urine collections.
Under or over collections of 24 h urine samples were
defined as the lower and upper 2.5% of the difference
between the measured GFR ([urine creatinine]*24 h urine
volume/[serum creatinine]) and estimated GFR (using the
CKD-EPI equation). We performed these sensitivity anal-
yses in a subgroup in which urine creatinine concentra-
tions were available (n=484) [24].
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Results
The correlation between the two 24 h urine samples was r=
0.60 (p<0.001) for sodium excretion and r=0.56 (p<0.001)
for potassium excretion, and the correlation between urinary
sodium and potassium excretion was r=0.44 (p<0.001). The
average 24 h urinary sodium excretion rate was 4.0 g/day,
which roughly corresponds to a dietary salt intake of 9.9 g/day.
Table 1 shows the general characteristics of the 1,212
individuals of the EURODIAB study population at follow-
up (1997) with available data on urinary sodium and potassi-
um excretion. Data are presented for the total population (n=
1,212) and stratified according to categories of dietary salt
intake.
Individuals with higher salt intake were more often men
and had on average higher values of BMI, urinary volume,











Age (years) 39.9±9.8 39.6±9.4 39.5±9.6 40.4±10.2 0.21
Male sex (%) 51 43 45 61 <0.001
BMI (kg/m2) 24.7±3.3 24.0±2.9 24.7±3.5 25.1±3.3 <0.001









Duration of diabetes (years) 21.8±9.3 21.9±9.0 21.7±9.7 21.7±9.2 0.78
Total cholesterol (mmol/l) 5.3±1.1 5.3±1.1 5.2±1.0 5.4±1.2 0.37
LDL cholesterol (mmol/l) 3.2±1.0 3.2±0.9 3.0±0.9 3.3±1.1 0.23
HDL cholesterol (mmol/l) 1.6±0.4 1.6±0.4 1.6±0.5 1.6±0.4 0.21
Triacylglycerols (mmol/l) 1.0 (0.8–1.4) 1.0 (0.8–1.4) 0.9 (0.8–1.3) 1.0 (0.8–1.4) 0.51
Smoking (never/ex/current) (%) 42/29/29 43/29/28 46/27/27 39/31/30 0.14
Systolic BP (mmHg) 121±19 120±19 122±19 122±19 0.25
Diastolic BP (mmHg) 74±12 73±12 74±12 75±12 0.059
Use of antihypertensive medication (%) 25 27 22 25 0.57
Use of ACE inhibitors (%) 21 22 17 22 0.94
Use of diuretics (%) 4 5 3 4 0.20
Estimated GFR (ml/min) 102 (90–112) 102 (86–111) 103 (90–111) 103 (92–113) 0.049
Urinary volume (l) 1.8±0.7 1.6±0.6 1.7±0.6 2.1±0.7 <0.001
Urinary creatinine (mmol)a 11.7±3.9 10.0±3.4 11.3±3.6 13.3±3.8 <0.001
CVD (%) 13 13 12 13 0.66
Albuminuria (normo/micro/macro) (%) 71/17/12 73/14/13 76/15/9 67/20/13 0.11
Retinopathy (none/non-proliferative/proliferative) (%) 31/48/21 31/47/22 33/44/23 29/52/19 0.75
Urinary sodium excretion (g/day) 3.96±1.60 2.29±0.53 3.49±0.28 5.43±1.25 NA
Urinary sodium excretion (mmol/day) 172±69 100±23 152±12 236±54 NA
Urinary potassium excretion (g/day) 2.91±1.09 2.40±0.90 2.80±0.95 3.34±1.14 <0.001
Urinary potassium excretion (mmol/day) 75±28 62±23 72±24 86±29 <0.001
Physical activity (0/≤medianb/ >median) (%) 60/20/19 61/22/17 57/24/19 62/16/21 0.70
Total energy intake (kJ/day) 9856±2887 9147±2620 9590±2718 10522±3030 <0.001
Protein intake (g/day) 97.8±29.1 90.5±27.1 93.8±26.7 105.6±30.2 <0.001
Alcohol intake (0/≤medianc, >median [%]) 45/27/28 42/27/31 49/25/26 44/29/27 0.55
Saturated fat intake (g/day) 35.8±15.3 33.2±14.4 35.1±14.2 37.9±16.2 <0.001
Fibre intake (g/day) 19.9±8.5 18.1±7.2 19.2±8.0 21.5±9.4 <0.001
Data are presented as means ± SD, medians (interquartile range) or percentages, as appropriate
a urinary creatinine was only available in n=489
b sex-specific medians for physical activity were 9.6 MET-h/week for men and 7.3 MET-h/week for women
c sex-specific medians for alcohol intake were 12.7 g/day for men and 7.1 g/day for women
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urinary creatinine and potassium excretion, and higher total
energy and protein intake (Table 1).
After adjustment for age and sex, we found no associations
between dietary salt intake (per 1 g/day) and systolic BP
(–0.14 mmHg [95% CI –0.39, 0.12]) or diastolic BP (0.02
[–95% CI 0.15, 0.19]).
Associations between dietary salt intake and microvascular
complications After adjustment for age and sex, >10 g/day
salt intake, when compared with <7.5 g/day salt intake, was
positively associated with the prevalence of microalbuminuria
(OR 1.46 [95% CI 1.00, 2.13]). After full adjustment a similar
association with microalbuminuria was found (OR 1.40 [95%
CI 0.92, 2.15]), although this was no longer significant (ESM
Table 1). When individuals with CVD and/or those who used
antihypertensive medication were excluded we found a simi-
lar positive, although non-significant, association between
>10 g/day salt intake and microalbuminuria (OR 1.26 [95%
CI 0.74, 2.15]) and macroalbuminuria (OR 1.34 [95% CI
0.55, 3.27]) compared with <7.5 g/day salt intake (ESM
Table 2). We found no consistent associations between 7.5–
10 g/day or >10 g/day salt intake and non-proliferative or
proliferative retinopathy, when compared with <7.5 g/day salt
intake either in the total population (ESM Table 1) or after
exclusion of individuals with CVD and/or antihypertensive
medication (ESM Table 2). In addition, we found no signifi-
cant associations between the quadratic terms of salt intake
and microvascular complications (all p>0.46). Taken togeth-
er, these analyses provide no consistent evidence for non-
linear associations between salt intake and microvascular
complications. We therefore present all further analyses per
1 g/day higher salt intake.
After adjustment for age and sex, 1 g/day higher dietary salt
intake was positively associated with microalbuminuria (OR
1.06 [95%CI 1.02, 1.10]) but not with macroalbuminuria (OR
1.00 [95% CI 0.95, 1.04]), non-proliferative retinopathy (OR
1.02 [95% CI 0.98, 1.05]) or proliferative retinopathy (OR
0.99 [95% CI 0.94, 1.03]) (Table 2). After excluding
individuals with CVD and/or antihypertensive medication
(n=418), we found a similar positive association with
microalbuminuria (OR 1.05 [95% CI 1.00, 1.11]) and also,
although not significantly so, with macroalbuminuria (OR
1.04 [95% CI [0.96; 1.13]), with no associations for non-
proliferative retinopathy (OR 1.01 [95% CI 0.97, 1.05]) or
proliferative retinopathy (OR 1.02 [95% CI 0.95, 1.09])
(Table 3). Essentially the same results were found in the
fully adjusted models (Tables 2 and 3).
We found no consistent significant additive or multiplica-
tive interactions between salt intake and urinary potassium
excretion or kidney function in the associations with micro-
vascular complications (data not shown). However, in the
association between salt intake and microalbuminuria we did
find an interaction with BMI (p for multiplicative interaction
0.050 and RERI 0.02 [95% CI –0.02, 0.07)] such that the
association was stronger in individuals with BMI >25 kg/m2
(OR 1.11 [95%CI 1.04, 1.18]) than in thosewith BMI <25 kg/m2
(OR 1.03 [95% CI 0.97, 1.09]).
Associations between urinary potassium excretion and micro-
vascular complications After adjustment for age and sex we
found no significant associations between urinary potassium
excretion (in g/day) and microalbuminuria (OR 1.09 [95% CI
0.95, 1.25]), macroalbuminuria (OR 0.98 [95% CI 0.83,
1.16]) and non-proliferative (OR 1.12 [95% CI 0.98, 1.27])
or proliferative (OR 0.87 [95% CI 0.73, 1.04]) retinopathy
(Table 4). Similarly, no significant associations were found
after full adjustment (Table 4) or when individuals with CVD
and/or those who used antihypertensive medication were ex-
cluded (Table 5). In addition, we found no consistent signif-
icant additive or multiplicative interactions of urinary potassi-
um excretion with urinary sodium excretion, kidney function
or BMI (data not shown).
Additional analyses Use of salt intake <5.0 g/day (n=85)
instead of <7.5 g/day (n=352) as a reference category did
not materially change our results (data not shown).









Model OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
1 1.06 1.02, 1.10 0.003 1.00 0.95, 1.04 0.88 1.02 0.98, 1.05 0.34 0.99 0.94, 1.03 0.53
2 1.06 1.01, 1.10 0.011 1.00 0.94, 1.06 0.95 1.00 0.96, 1.04 0.94 1.02 0.96, 1.08 0.64
3 1.06 1.01, 1.10 0.013 0.99 0.94, 1.05 0.82 1.00 0.96, 1.04 0.84 1.02 0.95, 1.08 0.65
OR indicates the odds of prevalent albuminuria or retinopathy per g/day salt intake
Model 1: adjusted for age and sex
Model 2: model 1 + BMI, smoking (never/ex/current), urinary potassium excretion and use of antihypertensive medication
Model 3: model 2 + physical activity (0/≤sex-specific median/>sex-specific median), total energy intake, protein intake, saturated fat intake, fibre intake,
alcohol intake (0/≤sex-specific median/>sex-specific median)
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Sensitivity analyses In the subgroup of 484 individuals who
had urine creatinine values available we found a positive
association between dietary salt intake and microalbuminuria
(OR 1.12 [95% CI 1.04, 1.22] after full adjustment), which
was similar after exclusion of individuals with potential under
or over 24 h urine collections (n=24; OR 1.12 [95% CI 1.03,
1.22]).
Complete case analyses showed similar results to the mul-
tiple imputation analyses as presented throughout the
manuscript.
Discussion
The present study showed that in individuals with type 1
diabetes, higher dietary salt intake, as estimated by 24 h
urinary sodium excretion, was associated with a higher prev-
alence of microalbuminuria, an association that was more
pronounced in overweight individuals, but not with
macroalbuminuria or retinopathy. In addition, no significant
associations were found between urinary potassium excretion
and the prevalence of microvascular complications.
Previous studies on the cross-sectional association between
dietary salt intake and microalbuminuria in the general popu-
lation have been conflicting, that is both no [4, 8] and positive
[5–7, 9] associations have been described. Interestingly, these
positive associations were more pronounced in individuals
with a higher BMI [5] or were found only in obese individuals
[7]. The present results of a more pronounced positive asso-
ciation between dietary salt intake and microalbuminuria in
individuals with type 1 diabetes and a BMI >25 kg/m2 support
previous findings [5, 6]. Overweight and obesity have been
associated with both salt sensitivity [7, 25] and increased
glomerular filtration fraction and GFR [26], which might
explain the stronger associations between salt intake and
microalbuminuria.
In contrast, two studies in individuals with type 2 [10] or
type 1 diabetes [11] found inverse (or J-shaped) associations
between dietary salt intake and prevalent microalbuminuria
[10] or incident end-stage renal disease [11]. These findings
are in line with several other recent studies that showed J-
shaped associations between dietary salt intake and incident
CVD and mortality in general [27], as well as in high-risk
populations [28] and in individuals with type 1 [11] and type 2










Model OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
1 1.05 1.00, 1.11 0.049 1.04 0.96, 1.13 0.36 1.01 0.97, 1.05 0.66 1.02 0.95, 1.09 0.63
2 1.04 0.98, 1.10 0.17 1.05 0.96, 1.15 0.30 0.98 0.94, 1.03 0.44 1.02 0.95, 1.10 0.54
3 1.04 0.99, 1.10 0.14 1.05 0.96, 1.16 0.30 0.98 0.93, 1.02 0.32 1.02 0.95, 1.10 0.59
OR indicates the odds of prevalent albuminuria or retinopathy per g/day salt intake
Model 1: adjusted for age and sex
Model 2: model 1 + BMI, smoking (never/ex/current) and urinary potassium excretion
Model 3: model 2 + physical activity (0/≤sex-specific median/>sex-specific median), total energy intake, protein intake, saturated fat intake, fibre intake,
alcohol intake (0/≤sex-specific median/>sex-specific median)









Model OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
1 1.09 0.95, 1.25 0.20 0.98 0.83, 1.16 0.79 1.12 0.98, 1.27 0.10 0.87 0.73, 1.04 0.13
2 1.03 0.88, 1.20 0.76 1.04 0.85, 1.28 0.71 1.10 0.94, 1.28 0.24 0.84 0.67, 1.05 0.12
3 1.03 0.88, 1.22 0.68 1.07 0.86, 1.32 0.57 1.11 0.95, 1.30 0.20 0.88 0.69, 1.12 0.29
OR indicates the odds of prevalent albuminuria or retinopathy per g/day potassium excretion
Model 1: adjusted for age and sex
Model 2: model 1 + BMI, smoking (never/ex/current), urinary sodium excretion and use of antihypertensive medication
Model 3: model 2 + physical activity (0/≤sex-specific median/>sex-specific median), total energy intake, protein intake, saturated fat intake, fibre intake,
alcohol intake (0/≤sex-specific median/>sex-specific median)
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diabetes [29]. However, several methodological aspects of
these studies have been criticised, such as the use of a single
24 h urine sample, which may poorly represent usual sodium
intake at the individual level [30, 31], potential problematic
completeness of urine collection [30] and unmeasured and
residual confounding [32]. Furthermore, the low salt-intake
groups may have included persons who followed a low salt
diet, which may have been recommended to those with hy-
pertension or otherwise increased CVD risk, which could
have biased the findings [31]. In addition, in the present study
we found no evidence for such non-linear associations be-
tween dietary salt intake and microvascular complications.
Whether or not low dietary salt intake is associated with
increased cardiovascular risk and/or microvascular complica-
tions thus remains to be established.
Potassium has been shown to exert an inhibitory effect on
sodium sensitivity [13], and the association between sodium
intake and microvascular complications may thus be modified
by potassium intake. In addition, high sodium intake in combi-
nation with low potassium intake results in further excess of
sodium in the body and higher BP [13]. However, we did not
find evidence to support an effect-modifying role of potassium
excretion in the association between sodium excretion and mi-
crovascular complications nor that of an (inverse) association
between potassium excretion and microvascular complications
in individuals with type 1 diabetes. In addition, although indi-
viduals with decreased kidney function are more commonly BP
salt-sensitive, and kidney function may thus modify the associ-
ation between dietary salt intake and microvascular complica-
tions, we found no evidence to support this contention. However,
we may have lacked power to show this association, and larger
and prospective studies are needed to fully address these issues.
Increasing dietary salt intake increases BP in salt-sensitive
individuals both with [33] and without [34] type 1 diabetes. In
individuals with type 1 diabetes, elevated BP has been asso-
ciated with the development of microalbuminuria [35], which
may result from an increase in the ratio of GFR to the renal
plasma flow, i.e. an increased glomerular filtration fraction,
with a resultant increase in proteinuria [34]. In the current
study, however, higher dietary salt intake was not associated
with elevated BP. Individuals with elevated BP may have
changed their dietary habits to reduce salt intake, which may
have masked these cross-sectional associations. However, the
association between dietary salt intake and microalbuminuria
may also be mediated by processes other than increases in BP.
High salt intake may activate the local renin–angiotensin–
aldosterone system in the vessels as well as in the kidney
[36], stimulating the secretion of aldosterone, and this may
have detrimental effects on endothelium-dependent dilation
[37] as it may stimulate central sympathetic outflow creating a
hyperadrenergic state [38] and the formation of reactive oxy-
gen species suppressing nitric oxide availability [39]. Similar
effects of aldosterone may be exerted via increased signalling
of the mineralocorticoid receptor resulting from or in combi-
nation with high salt intake [40]. However, we cannot draw
any conclusions of a cause-and-effect relationship between
salt intake and microalbuminuria based on the current cross-
sectional study.
Although the current study is the largest study investigating
the association between dietary salt intake and (early) micro-
vascular complications in individuals with type 1 diabetes so
far, a limitation that needs to be addressed is the cross-sectional
design. We cannot exclude that individuals with prior CVD
and/or known (treated) hypertension have received dietary
advice to reduce their salt intake, which may have masked
the associations. We have therefore performed all analyses not
only in the total population but also in the individuals without
prevalent CVD and/or antihypertensive medication. However,
the analyses in this subpopulation might have been underpow-
ered due to low numbers of microvascular complication cases
in particular of macroalbuminuria. Further investigation in
larger, prospective studies is warranted to address the role of
dietary salt intake in the development of microvascular com-
plications in type 1 diabetes.
Table 5 Continuous associations between urinary potassium excretion and prevalent albuminuria and retinopathy in individuals without CVD who did









Model OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
1 1.12 0.95, 1.33 0.18 0.92 0.68, 1.25 0.60 1.15 0.99, 1.33 0.074 0.88 0.69, 1.14 0.34
2 1.06 0.88, 1.28 0.55 0.85 0.60, 1.20 0.35 1.15 0.97, 1.36 0.10 0.84 0.63, 1.11 0.21
3 1.07 0.88, 1.30 0.52 0.82 0.57, 1.17 0.28 1.16 0.98, 1.39 0.090 0.91 0.68, 1.22 0.52
OR indicates the odds of prevalent albuminuria or retinopathy per g/day potassium excretion
Model 1: adjusted for age and sex
Model 2: model 1 + BMI, smoking (never/ex/current) and urinary sodium excretion
Model 3: model 2 + physical activity (0/≤sex-specific median/>sex-specific median), total energy intake, protein intake, saturated fat intake, fibre intake,
alcohol intake (0/≤sex-specific median/>sex-specific median)
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In conclusion, in individuals with type 1 diabetes, high
dietary salt intake may be a risk factor for microalbuminuria,
particularly in overweight individuals, and nutritional advice
regarding salt intake may thus be important in preventing or
slowing the rate of development of microvascular disease in
individuals with type 1 diabetes. Further investigation in
prospective studies is warranted to fully address the role of
dietary salt intake in the development of microvascular com-
plications in type 1 diabetes.
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